News
2h
Stocktwits on MSNPfizer In Spotlight As FDA Reportedly Mulls Withdrawing Authorization For COVID-19 Vaccine For Kids Under 5: Retail Says Stock Is UndervaluedThe U.S. Food and Drug Administration (FDA) is reportedly considering revoking the authorization granted to Pfizer Inc. (PFE) ...
Shortly after that, the CDC overhauled its vaccine recommendations in COVID, nixing its endorsement of the shots for pregnant women and healthy children. At the time, RFK Jr. said he “couldn’t be more ...
The FDA is considering pulling Pfizer’s (PFE) authorization to sell its Covid vaccine for children under the age of 5, Bloomberg’s Damian Garde reports. Pfizer has requested the authorization remain ...
Pfizer (PFE) stock and BioNTech (BNTX) stock in focus as FDA may not renew the authorization for their pediatric COVID shot. Read more here.
This fall, it may not be possible for many parents to have a healthy child younger than age 5 immunized against COVID.
The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be retreating from them.
Those who invested in Pfizer three years ago and hung on are not thrilled. They would have done much better with a simple S&P ...
Pfizer's COVID-19 vaccine for children under five may lose FDA authorization, leading to potential supply shortages. Modern ...
A Fallen Giant Pfizer (NYSE:PFE) has been a bitter pill for investors to swallow. Down 19% from its 52-week high of $30.43 per share, PFE stock has plummeted over 50% in the past three years, a stark ...
Here are two beaten-down stocks that long-term investors might want to consider buying on the dip and holding for several ...
Robert F. Kennedy Jr., the health secretary and a longtime vaccine critic, announced in a statement Tuesday that $500 million ...
So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using that Nobel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results